The HEAL4LIV consortium aims to develop an innovative, modular robotic system for HepatoCellular Carcinoma (HCC) treatment capable of:

  • Percutaneous HDR brachytherapy;

  • Radiofrequency ablation;

  • Targeted intratumoral chemotherapy;


The main objectives of the project are:

(O1) Acquire the Proof of Feasibility of the robotic system: model and positive feedback from clinicians. (Details: Obtain positive feedback from 20+ clinicians and end-users. Feedback reports. Update workflow)

(O2) Realize the Preliminary business model and plan for investor atraction. (Obtain positive feedback from a minimum of 5 economic buyers (including private clinics) and possible business partners)